In addition, overexpression of LSD1 protein correlates with disease progression and poor prognosis in hepatocellular carcinoma patients [29], and promotes recurrence and elevated VEGF-A expression in prostate cancer patients [30]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.